{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:53:53Z","timestamp":1790045633471,"version":"4.0.1"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejmech.2019.111847","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:55:02Z","timestamp":1572954902000},"page":"111847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Indole-based melatonin analogues: Synthetic approaches and biological activity"],"prefix":"10.1016","volume":"185","author":[{"given":"Su-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Chi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Laborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111847_bib1","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","article-title":"Melatonin - nature\u2019s most versatile biological signal?","volume":"273","author":"Pandi-Perumal","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2019.111847_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biocel.2005.08.020","article-title":"Melatonin","volume":"38","author":"Hardeland","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.111847_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1097-2765(00)80171-9","article-title":"Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 angstrom resolution suggests a catalytic mechanism","volume":"3","author":"Hickman","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.111847_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.drudis.2014.04.014","article-title":"Melatonin: functions and ligands","volume":"19","author":"Singh","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111847_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12531","article-title":"Metabolic analysis of the melatonin biosynthesis pathway using chemical labeling coupled with liquid chromatography-mass spectrometry","volume":"66","author":"Ye","year":"2019","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2012.08.009","article-title":"An underappreciated player in retinal physiology and pathophysiology","volume":"103","author":"Tosini","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157015910792246155","article-title":"Antiinflammatory activity of melatonin in central nervous system","volume":"8","author":"Esposito","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/ppa.12954","article-title":"Melatonin treatments reduce the pathogenicity and inhibit the growth of Xanthomonas oryzae pv. oryzicola","volume":"68","author":"Chen","year":"2019","journal-title":"Plant Pathol."},{"key":"10.1016\/j.ejmech.2019.111847_bib9","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3389\/fmicb.2018.02280","article-title":"Melatonin treatment inhibits the growth of Xanthomonas oryzae pv. oryzae","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111847_bib10","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1016\/j.ejmech.2010.07.059","article-title":"Antioxidant activity of unexplored indole derivatives: synthesis and screening","volume":"45","author":"Estevao","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib11","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.ejmech.2008.12.017","article-title":"Quantum-chemical and biochemical investigation of antioxidant activity","volume":"44","author":"Velkov","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms14022410","article-title":"Melatonin anticancer effects: Review","volume":"14","author":"Di Bella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2050-6511-15-40","article-title":"Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial","volume":"15","author":"de Zanette","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111847_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12490","article-title":"Melatonin and cardioprotection against ischaemia\/reperfusion injury: What\u2019s new? A review","volume":"65","author":"Lochner","year":"2018","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/NDT.S4815","article-title":"Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages","volume":"5","author":"Lin","year":"2009","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmech.2019.111847_bib16","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.3390\/ijms14059379","article-title":"Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia","volume":"14","author":"Alonso-Alconada","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib17","doi-asserted-by":"crossref","first-page":"109150","DOI":"10.1016\/j.biopha.2019.109150","article-title":"Protective effects of melatonin on sepsis-induced liver injury and dysregulation of gluconeogenesis in rats through activating SIRT1\/STAT3 pathway","volume":"117","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.111847_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41440-019-0223-9","article-title":"Melatonin in chronic kidney disease: a promising chronotherapy targeting the intrarenal renin\u2013angiotensin system","volume":"42","author":"Rahman","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038795","article-title":"Maternal melatonin programs the daily pattern of energy metabolism in adult offspring","volume":"7","author":"Ferreira","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111847_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0140-6736(91)92787-3","article-title":"Delayed sleep phase syndrome response to melatonin","volume":"337","author":"Dahlitz","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.111847_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","article-title":"Melatonin and its analogs in insomnia and depression","volume":"52","author":"Cardinali","year":"2012","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12544","article-title":"Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep","volume":"66","author":"Gobbi","year":"2019","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2019.111847_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41586-019-1141-3","article-title":"Structural basis of ligand recognition at the human MT1 melatonin receptor","volume":"569","author":"Stauch","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111847_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-019-1144-0","article-title":"XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity","volume":"569","author":"Johansson","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111847_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-079X.2007.00513.x","article-title":"Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: Hypothesis and significance","volume":"43","author":"Tan","year":"2007","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2148-8-105","article-title":"GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals","volume":"8","author":"Dufourny","year":"2008","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.ejmech.2019.111847_bib28","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.ejmech.2008.02.012","article-title":"A\u00a0novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site","volume":"43","author":"Du","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2005.12.002","article-title":"New ligands at the melatonin binding site MT3","volume":"41","author":"Boussard","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.118.253260","article-title":"Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2?","volume":"368","author":"Boutin","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111847_bib31","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/bph.13536","article-title":"Update on melatonin receptors: IUPHAR review 20","volume":"173","author":"Jockers","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111847_bib33","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/jm401343c","article-title":"MT1 and MT2 melatonin receptors: ligands, models, oligomers and therapeutic potential","volume":"57","author":"Zlotos","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib34","first-page":"127","article-title":"Melatonergic drugs in development","volume":"6","author":"Carocci","year":"2014","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib35","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1460-9568.2009.06718.x","article-title":"Antagonism of serotonergic 5-HT2A\/2C receptors: Mutual improvement of sleep, cognition and mood?","volume":"29","author":"Landolt","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111847_bib36","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.2174\/092986712801323153","article-title":"Recent progress in the development of agonists and antagonists for melatonin receptors","volume":"19","author":"Zlotos","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111847_bib38","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3987\/REV-03-567","article-title":"Short syntheses of melatonin","volume":"60","author":"Hugel","year":"2003","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00304949509458177","article-title":"Synthesis and chemistry of melatonin and of related compounds. A review","volume":"27","author":"Hugel","year":"1995","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2019.111847_bib40","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/jo0110597","article-title":"Aromatization of 1,6,7,7a-tetrahydro-2H-indol-2-ones by a novel process. Preparation of key-intermediate methyl 1-benzyl-5-methoxy-1H-indole-3-acetate and the syntheses of serotonin, melatonin, and bufotenin","volume":"67","author":"Revial","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/jo01075a623","article-title":"Synthesis of N-acetyl-5-methoxytryptamine","volume":"25","author":"Szmuszkovicz","year":"1960","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib42","first-page":"83","article-title":"The synthesis of 3,5-disubstituted indoles by cyclization under mild conditions","volume":"33","author":"Keglevi\u0107","year":"1961","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.ejmech.2019.111847_bib43","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/00397919908086203","article-title":"A\u00a0practical synthesis of N-acetyl-5-methoxytryptamine (melatonin)","volume":"29","author":"Hwang","year":"1999","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib44","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1039\/b003715j","article-title":"Selective hydroformylation of N-allylacetamide in an inverted aqueous two-phase catalytic system, enabling a short synthesis of melatonin","author":"Verspui","year":"2000","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib45","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1080\/00397919808004915","article-title":"On a facile synthesis of melatonin and other related indoles","volume":"28","author":"Marais","year":"1998","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib46","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/ol302034r","article-title":"Fischer indole synthesis in low melting mixtures","volume":"14","author":"Gore","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib47","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1039\/JR9560004589","article-title":"880. Tryptamines, carbolines, and related compounds. Part II. A convenient synthesis of tryptamines and \u03b2-carbolines","author":"Abramovitch","year":"1956","journal-title":"J.\u00a0Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111847_bib48","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1021\/ja01629a113","article-title":"Application of the Japp-Klingemann reaction. A new synthesis of ornithine","volume":"77","author":"Shapiro","year":"1955","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111847_bib49","first-page":"345","article-title":"New synthesis of 5-nitro- and 5-benzyloxytryptamine and their N-acylderivatives","volume":"36","author":"Misztal","year":"1984","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib50","unstructured":"K. Xiong, J. Zhao. Chinese Patent CN104496882A, 2014."},{"key":"10.1016\/j.ejmech.2019.111847_bib51","unstructured":"F. Fraschini, L. Di Bella, E. Duranti, M. T. M. Duranti, L. Duranti. US Patent Re. 35,631, 1997."},{"key":"10.1016\/j.ejmech.2019.111847_bib52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1039\/B204371H","article-title":"A\u00a0convergent approach to 2-substituted-5-methoxyindoles. Application to the synthesis of melatonin","author":"Quiclet-Sire","year":"2002","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib53","doi-asserted-by":"crossref","DOI":"10.1081\/SCC-120024751","article-title":"Efficient route to the pineal hormone melatonin by radical-based indole synthesis","volume":"33","author":"Thomson","year":"2003","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib54","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3987\/COM-00-8930","article-title":"Syntheses of melatonin and its derivatives","volume":"53","author":"Somei","year":"2000","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib55","first-page":"91","article-title":"Syntheses of serotonin, N-methylserotonin, bufotenine, and melatonin, and the first total synthesis of N-(indol-3-yl)methyl-N-methyl-5-methoxytryptamine from tryptamine through a common intermediate, 1-hydroxytryptamine","volume":"29","author":"Somei","year":"1998","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/jm00187a015","article-title":"Synthesis and evaluation of the antiovulatory activity of a variety of melatonin analogs","volume":"22","author":"Flaugh","year":"1979","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2001-10812","article-title":"Preparation and reactions of 4-, 5-, and 6-methoxy substituted 3-lithioindoles and 3-indolylzinc derivatives","volume":"32","author":"Amat","year":"2001","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.111847_bib58","first-page":"643","article-title":"Synthesis and antioxidant properties of some indole ethylamine derivatives as melatonin analogues","volume":"36","author":"Ates-Alagoz","year":"2005","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.ejmech.2019.111847_bib59","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1021\/jo3010028","article-title":"Synthesis of tryptamine derivatives via a direct, one-pot reductive alkylation of indoles","volume":"77","author":"Righi","year":"2012","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib60","unstructured":"S. Iyimen, G. Lehmann, O. Neunhoeffer, O. Vitzthum. German Patent 2156944A1, 1971."},{"key":"10.1016\/j.ejmech.2019.111847_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1039\/b210731g","article-title":"Design and synthesis of potent N1-substituted indole melatonin receptor agonists","author":"Tsotinis","year":"2003","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib62","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/jm9810093","article-title":"Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study","volume":"41","author":"Mor","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/157340607782360335","article-title":"Design and synthesis of new N-OMe fluoro-indole melatoninergics","volume":"3","author":"Tsotinis","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib64","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1039\/c4md00079j","article-title":"N1-Linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors","volume":"5","author":"Journ\u00e9","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111847_bib65","first-page":"684760","article-title":"Design and synthesis of sustain-acting melatonin prodrugs","author":"Pham Van","year":"2013","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-079X.2008.00655.x","article-title":"N-Nitrosomelatonin: synthesis, chemical properties, potential prodrug","volume":"46","author":"Kirsch","year":"2009","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib67","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1074\/jbc.M300237200","article-title":"Regiospecific nitrosation of N-terminal-blocked tryptophan derivatives by N2O3 at physiological pH","volume":"278","author":"Kirsch","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-079X.2005.00277.x","article-title":"Detection of N-nitrosomelatonin and other N-nitrosotryptophan derivatives by transnitrosation of APF and DAF-2","volume":"40","author":"Kirsch","year":"2006","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jnc.12613","article-title":"N-Nitrosomelatonin enhances photic synchronization of mammalian circadian rhythms","volume":"129","author":"Baidanoff","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111847_bib70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0223-5234(02)01410-1","article-title":"Receptor-binding studies of 1-N-substituted melatonin analogues","volume":"37","author":"Lira-Rocha","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib71","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1016\/j.bmc.2012.07.027","article-title":"Cytotoxic and antioxidant evaluations of amino derivatives from perezone","volume":"20","author":"Lozada","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acs.chemrestox.8b00216","article-title":"Design, synthesis, and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids","volume":"32","author":"Bedini","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111847_bib73","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3987\/COM-03-9746","article-title":"Water-soluble melatonins: syntheses of melatonins carrying a glycosyl group at the 1-position","volume":"60","author":"Iwaki","year":"2003","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/cpb.50.31","article-title":"Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists","volume":"50","author":"Tsotinis","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.111847_bib75","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/jm960653j","article-title":"1-(2-Alkanamidoethyl)-6-methoxyindole derivatives:\u2009 A new class of potent indole melatonin analogues","volume":"40","author":"Tarzia","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/PL00004956","article-title":"Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor","volume":"355","author":"Dubocovich","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib77","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1021\/jm048956y","article-title":"Analysis of structure\u2212activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models","volume":"48","author":"Rivara","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib78","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/jo00335a038","article-title":"Lithiation of N-(2-alkylphenyl)alkanamides and related compounds. A modified Madelung indole synthesis","volume":"46","author":"Houlihan","year":"1981","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-079X.1992.tb00044.x","article-title":"High affinity specific binding of 2-[125I]iodomelatonin by spleen membrane preparations of chicken","volume":"12","author":"Pang","year":"1992","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib80","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1073\/pnas.84.11.3916","article-title":"Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina","volume":"84","author":"Dubocovich","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111847_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-079X.1997.tb00348.x","article-title":"Differential inhibitory effects of melatonin analogs and three naphthalenic ligands on 2-[125I]iodomelatonin binding to chicken tissues","volume":"23","author":"Pang","year":"1997","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib82","first-page":"152","article-title":"Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer","volume":"106","author":"Vakkuri","year":"1984","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ejmech.2019.111847_bib83","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/0969-8043(94)90224-0","article-title":"Improved radiosynthesis of 2-[123I]iodomelatonin","volume":"45","author":"Du","year":"1994","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2019.111847_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(95)00870-5","article-title":"2-[125I]Iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites","volume":"301","author":"Molinari","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apradiso.2005.06.012","article-title":"Synthesis and biodistribution of 2-[123I]iodomelatonin in normal mice","volume":"64","author":"Al-Jammaz","year":"2006","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2019.111847_bib86","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0969-8043(98)00005-0","article-title":"Synthesis of 2-iodo- and 2-phenyl-[11C]melatonin: potential PET tracers for melatonin binding sites","volume":"49","author":"Chen","year":"1998","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2019.111847_bib87","unstructured":"C. Tao, C. Z. Yu, N. Desai, V. Trieu. US Patent 2007\/0191463, 2007."},{"key":"10.1016\/j.ejmech.2019.111847_bib88","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0024-3205(92)90024-J","article-title":"Synthesis and characterization of a potent melatonin agonist","volume":"51","author":"Duranti","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-079X.2004.00174.x","article-title":"2-Iodomelatonin prevents apoptosis of cerebellar granule neurons via inhibition of A-type transient outward K+ currents","volume":"38","author":"Hu","year":"2005","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.1989.tb00668.x","article-title":"Antigonadal activity of the melatonin analogs 2-iodomelatonin and 2-chloromelatonin in the juvenile djungarian hamster, Phodopus sungorus campbetti","volume":"7","author":"Sugden","year":"1989","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib91","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0024-3205(93)90596-U","article-title":"Primary pharmaco-toxicological evaluation of 2-iodomelatonin, a potent melatonin agonist","volume":"53","author":"Stankov","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib92","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1021\/ol0259185","article-title":"Microwave-assisted solid-phase synthesis of 5-carboxamido-N-acetyltryptamine derivatives","volume":"4","author":"F\u00eenaru","year":"2002","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib93","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/qsar.200420046","article-title":"Solid phase synthesis of 2-substituted melatonin derivatives via palladium-mediated coupling reactions using microwave irradiation","volume":"23","author":"Berthault","year":"2004","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib94","first-page":"607","article-title":"Synthesis and study of pigment aggregation response of some melatonin derivatives","volume":"58","author":"Doss","year":"2003","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.ejmech.2019.111847_bib95","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0960-894X(01)80565-5","article-title":"Mapping the melatonin receptor. 1. The 5-methoxyl group of melatonin is not an essential requirement for biological-activity","volume":"4","author":"Garratt","year":"1994","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111847_bib96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0030-1258361","article-title":"Simple synthesis of some 2-substituted melatonin derivatives","author":"Lozinskaya","year":"2011","journal-title":"Synthesis (Stuttg.)"},{"key":"10.1016\/j.ejmech.2019.111847_bib97","first-page":"272","article-title":"Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma","volume":"11","author":"Chesnokova","year":"2017","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2019.111847_bib98","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1016\/j.bmcl.2012.10.005","article-title":"Synthesis of novel \u041c\u04223 receptor ligands via an unusual Knoevenagel condensation","volume":"22","author":"Volkova","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111847_bib99","unstructured":"J. B. Fourtillan, M. Fourtillan, J. C. Jacquesy, M. P. Jouannetaud, O. Karam, B. Violeau. German Patent 69617712T2, 2004."},{"key":"10.1016\/j.ejmech.2019.111847_bib100","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/jm800974d","article-title":"2-(2,3-Dihydro-1H-indol-1-yl)methyl melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists","volume":"52","author":"Zlotos","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib101","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1016\/j.bmc.2008.07.012","article-title":"Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands","volume":"16","author":"Attia","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib102","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1039\/c1md00149c","article-title":"2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin \u2013 receptor antagonist","volume":"2","author":"Heckman","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111847_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1752-153X-6-36","article-title":"New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]-ethyl}acetamide: a contaminant in commercial melatonin preparations","volume":"6","author":"Darwish","year":"2012","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2019.111847_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13065-016-0203-y","article-title":"Erratum to: new spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]-ethyl}acetamide: a contaminant in commercial melatonin preparations","volume":"10","author":"Darwish","year":"2016","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2019.111847_bib105","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1016\/j.bmc.2007.03.080","article-title":"Synthesis and biological activity of new melatonin dimeric derivatives","volume":"15","author":"Di Giacomo","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib106","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.bmc.2009.04.068","article-title":"Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-(phenylmethylamino)methyl-1H-indole analogues as novel melatoninergic ligands","volume":"17","author":"Markl","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2019.02.019","article-title":"Indole based antimalarial compounds targeting the melatonin pathway: their design, synthesis and biological evaluation","volume":"168","author":"Luthra","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib108","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/jm00007a010","article-title":"Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines","volume":"38","author":"Garratt","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib109","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1021\/jm00077a010","article-title":"2-Substituted-5-methoxy-N-acyltryptamines - synthesis, binding-affinity for the melatonin receptor, and evaluation of the biological activity","volume":"36","author":"Spadoni","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib110","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1016\/j.tet.2004.10.006","article-title":"Convenient synthesis of melatonin analogues: 2- and 3-substituted-N-acetylindolylalkylamines","volume":"60","author":"Nenajdenko","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.111847_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1070\/MC2006v016n04ABEH002280","article-title":"Mild and regioselective straightforward synthesis of isomelatonin analogues","volume":"16","author":"Zakurdaev","year":"2006","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2019.111847_bib112","unstructured":"T. Kanayama, S. Kubota, T. Matsumoto, S. Matsumoto, T. Saito, A. Shimizu, K. Naoto, S. Matsui. Chinese Patent CN104428286B, 2013."},{"key":"10.1016\/j.ejmech.2019.111847_bib113","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1096\/fasebj.12.12.1211","article-title":"Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms","volume":"12","author":"Dubocovich","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2019.111847_bib114","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(90)90290-M","article-title":"Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test","volume":"182","author":"Dubocovich","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib115","unstructured":"M. L. Dubocovich, V. J. Rajadhyaksha, J. V. Peck, A. A. Helmy. US Patent 5,283,343, 1991."},{"key":"10.1016\/j.ejmech.2019.111847_bib116","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1002\/ejoc.201800879","article-title":"Iodine-catalyzed metal-free oxidative ring opening of 1-aryltetrahydro-\u03b2-carbolines: facile synthesis of C-2 aroyl and aryl methanimino indole derivatives","author":"Chauhan","year":"2018","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib117","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-1989-27289","article-title":"Synthesis and reactions of 1-acetyl-2-benzylidene-3-oxo-2,3-dihydroindoles","volume":"21","author":"Buzas","year":"1989","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.111847_bib118","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/acscatal.7b01044","article-title":"Nickel-catalyzed C(sp2)\u2013H\/C(sp3)\u2013H oxidative coupling of indoles with toluene derivatives","volume":"7","author":"Soni","year":"2017","journal-title":"ACS Catal."},{"key":"10.1016\/j.ejmech.2019.111847_bib119","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/157017808785740561","article-title":"Melatonin receptor antagonist luzindole: a facile new synthesis","volume":"5","author":"Tsotinis A","year":"2008","journal-title":"Lett. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/PL00005288","article-title":"Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: Lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores","volume":"358","author":"Teh","year":"1998","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib121","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1021\/jm970721h","article-title":"2-[N-Acylamino(C-1-C-3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists","volume":"41","author":"Spadoni","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib122","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0968-0896(00)00322-9","article-title":"Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands","volume":"9","author":"Mor","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-079X.2005.00309.x","article-title":"Antioxidant activity and structure\u2013activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity","volume":"40","author":"Spadoni","year":"2006","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib124","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1021\/jm7010723","article-title":"Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles","volume":"50","author":"Tsotinis","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib125","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1021\/jm00046a006","article-title":"Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands","volume":"37","author":"Depreux","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib126","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.3390\/ijms14058948","article-title":"New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors","volume":"14","author":"Legros","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib127","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1023\/A:1012383125480","article-title":"Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests","volume":"26","author":"Chatterjie","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1600-079X.2003.00098.x","article-title":"Synthesis of internal labeled standards of melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine for their quantification using an on-line liquid chromatography\u2013electrospray tandem mass spectrometry system","volume":"36","author":"Almeida","year":"2004","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-079X.2007.00429.x","article-title":"NO-Donor melatonin derivatives: synthesis and in\u00a0vitro pharmacological characterization","volume":"42","author":"Chegaev","year":"2007","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib130","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.bmc.2016.07.025","article-title":"Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer\u2019s disease based on the fusion of donepezil and melatonin","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1039\/C8MD00484F","article-title":"Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents","volume":"10","author":"Xiong","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111847_bib132","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodriguez-Franco","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib133","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2014.03.055","article-title":"Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum","volume":"78","author":"Schuck","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib134","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2015.08.052","article-title":"New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer\u2019s disease","volume":"103","author":"Luo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib135","unstructured":"T. P. Schulman, M. Lawton. Chinese Patent CN101374833, 2012."},{"key":"10.1016\/j.ejmech.2019.111847_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(14)70212-3","article-title":"Development of piromelatine, a novel multimodal sleep medicine","volume":"24","author":"Laudon","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib137","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1124\/jpet.117.243998","article-title":"Melatonin receptor agonist piromelatine ameliorates impaired glucose metabolism in chronically stressed rats fed a high-fat diet","volume":"364","author":"Zhou","year":"2018","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111847_bib138","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10826060008544960","article-title":"Synthesis and analgesic activity of N,N\u2019-dicarbonyltryptamines","volume":"30","author":"Han","year":"2000","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.111847_bib139","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.119.116202","article-title":"Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs","volume":"96","author":"Hasan","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/14756360802218516","article-title":"Melatonin analogue new indole hydrazide\/hydrazone derivatives with antioxidant behavior: synthesis and structure-activity relationships","volume":"24","author":"Gurkok","year":"2009","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib141","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/14756366.2011.594048","article-title":"Synthesis and antioxidant activity evaluations of melatonin based analogue indole-hydrazide\/hydrazone derivatives","volume":"27","author":"Y\u0131lmaz","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib142","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1747-0285.2011.01216.x","article-title":"Synthesis and comparison of antioxidant properties of indole-based melatonin analogue indole amino acid derivatives","volume":"79","author":"Suzen","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111847_bib143","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/molecules15042187","article-title":"Novel indole-based analogs of melatonin: synthesis and in\u00a0vitro antioxidant activity studies","volume":"15","author":"Shirinzadeh","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111847_bib144","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1016\/j.ejmech.2010.05.067","article-title":"Synthesis, antioxidant and DNA cleavage activities of novel indole derivatives","volume":"45","author":"Biradar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib145","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/j.ejmech.2011.10.004","article-title":"Solvent-free, microwave assisted Knoevenagel condensation of novel 2,5-disubstituted indole analogues and their biological evaluation","volume":"46","author":"Biradar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib146","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/10286020.2017.1323885","article-title":"Bioactivity-guided synthesis of gramine derivatives as new MT1 and 5-HT1A receptors agonists","volume":"19","author":"Yin","year":"2017","journal-title":"J.\u00a0Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib147","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1211\/0022357021771869","article-title":"Design, synthesis and biological evaluation of novel \u03b2-substituted indol-3-yl ethylamido melatoninergic analogues","volume":"54","author":"Iakovou","year":"2002","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib148","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/14756366.2011.631183","article-title":"Synthesis of new indole-2-carboxamide and 3-acetamide derivatives and evaluation their antioxidant properties","volume":"28","author":"Olgen","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib149","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ardp.200600176","article-title":"Synthesis and antioxidant properties of novel N-H and N-substituted propanamide derivatives","volume":"340","author":"\u00d6lgen","year":"2007","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0014-827X(01)01150-8","article-title":"Synthesis and analytical evaluation by voltammetric studies of some new indole-3-propionamide derivatives","volume":"56","author":"S\u00fczen","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.ejmech.2019.111847_bib151","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2017.03.010","article-title":"Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores","volume":"131","author":"Devender","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib152","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10967-007-7166-3","article-title":"Tritiation of melatonin by several methods","volume":"279","author":"Ahern","year":"2008","journal-title":"J.\u00a0Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib153","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ardp.200500177","article-title":"Synthesis and antioxidant activity of new tetrahydro-naphthalene-indole derivatives as retinoid and melatonin analogs","volume":"339","author":"Ates-Alagoz","year":"2006","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib154","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.bmcl.2014.03.081","article-title":"Synthesis and in\u00a0vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages","volume":"24","author":"Furman","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111847_bib155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ardp.200400932","article-title":"Syntheses of novel indole lipoic acid derivatives and their antioxidant effects on lipid peroxidation","volume":"338","author":"Gurkan","year":"2005","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib156","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/j.bmc.2006.05.042","article-title":"Synthesis, pulse radiolysis, and in\u00a0vitro radioprotection studies of melatoninolipoamide, a novel conjugate of melatonin and \u03b1-lipoic acid","volume":"14","author":"Venkatachalam","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib157","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/cctc.201800369","article-title":"2D-2D Nanocomposite of MoS2-graphitic carbon nitride as multifunctional catalyst for sustainable synthesis of C3-functionalized indoles","volume":"10","author":"Bahuguna","year":"2018","journal-title":"ChemCatChem"},{"key":"10.1016\/j.ejmech.2019.111847_bib158","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1021\/acs.orglett.8b02335","article-title":"Synthesis of chiral tryptamines via a regioselective indole alkylation","volume":"20","author":"Wolfard","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib159","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1016\/j.bmc.2013.05.044","article-title":"Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies","volume":"21","author":"Buemi","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib160","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bmc.2013.12.040","article-title":"Modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors","volume":"22","author":"Gitto","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib161","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1055\/s-0036-1588601","article-title":"Base-free synthesis of CF3-containing \u03b2-tryptamine derivatives from N-nosyl-2-CF3-aziridine and indoles","volume":"27","author":"Hirotaki","year":"2016","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2019.111847_bib162","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1021\/jm0512544","article-title":"Mapping the melatonin receptor. 7. Subtype selective ligands based on \u03b2-substituted N-acyl-5-methoxytryptamines and \u03b2-substituted N-acyl-5-methoxy-1-methyltryptamines","volume":"49","author":"Tsotinis","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib163","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-1139(99)00044-5","article-title":"Regioselective electrophilic fluorination of indoles: syntheses of 4-fluoroserotonin and 4-fluoromelatonin","volume":"97","author":"Hayakawa","year":"1999","journal-title":"J.\u00a0Fluorine Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib164","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1021\/jm011053+","article-title":"Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT3","volume":"45","author":"Leclerc","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib165","first-page":"531","article-title":"Synthesis and the biological evaluation of N-fatty acyl derivatives of 4,5-dimethoxy tryptamine","volume":"56B","author":"Venepally","year":"2017","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib166","doi-asserted-by":"crossref","first-page":"1800194","DOI":"10.1002\/ardp.201800194","article-title":"Donepezil\u2013melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments","volume":"351","author":"\u0141ozi\u0144ska","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib167","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ardp.201100125","article-title":"N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1)-selectivity","volume":"344","author":"Markl","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2019.111847_bib168","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1039\/C5MD00190K","article-title":"Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT1 selectivity","volume":"6","author":"Zlotos","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.111847_bib169","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bioorg.2019.01.004","article-title":"O-Linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors","volume":"85","author":"Karamitri","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-0633.2002.290406.x","article-title":"A\u00a0new melatonin receptor ligand with MT1-agonist and MT2-antagonist properties","volume":"29","author":"Nonno","year":"2000","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib171","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/cmdc.200600133","article-title":"Towards the development of mixed MT1-agonist\/MT2-antagonist melatonin receptor ligands","volume":"1","author":"Spadoni","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111847_bib172","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/acs.jmedchem.8b00893","article-title":"Identification of bivalent ligands with melatonin receptor agonist and fatty acid amide hydrolase (FAAH) inhibitory activity that exhibit ocular hypotensive effect in the rabbit","volume":"61","author":"Spadoni","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib173","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/jcem-60-1-114","article-title":"Melatonin is metabolized to N-acetyl serotonin and 6-hydroxymelatonin in man","volume":"60","author":"Young","year":"1985","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2019.111847_bib174","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.lfs.2004.03.023","article-title":"A\u00a0single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, phannacokinetics and pharmaeodynamics of the melatonin analog \u03b2-methyl-6-chloromelatonin","volume":"75","author":"Mulchahey","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib175","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1039\/j39670001681","article-title":"Synthesis of 3-(2-acetylaminoethyl)-6-hydroxy-5-methoxyindole (6-hydroxymelatonin)","author":"Hall","year":"1967","journal-title":"J.\u00a0Chem. Soc. C Org."},{"key":"10.1016\/j.ejmech.2019.111847_bib176","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/jm00330a028","article-title":"6-Hydroxyindoles and the metabolism of melatonin","volume":"8","author":"Taborsky","year":"1965","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib177","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0040-4039(02)02763-6","article-title":"An efficient synthesis of 6-hydroxymelatonin, a human metabolite of melatonin","volume":"44","author":"Karam","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib178","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-079X.1988.tb00885.x","article-title":"Rapid and simple synthesis for the sulphate esters of 6-hydroxy-melatonin and N-acetyl-serotonin","volume":"5","author":"Leone","year":"1988","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib179","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12474","article-title":"A\u00a0unified model of melatonin, 6-sulfatoxymelatonin, and sleep dynamics","volume":"64","author":"Abeysuriya","year":"2018","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.ejmech.2019.111847_bib180","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-1983-30579","article-title":"Synthesis of N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)]ethyl-acetamide (6-chloromelatonin)","volume":"1983","author":"H\u00fcgel","year":"1983","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.111847_bib181","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1021\/jo9711798","article-title":"Indoles from o-haloanilines: syntheses of tryptamines and tryptophols via regioselective hydroformylation of functionalized anilines","volume":"62","author":"Dong","year":"1998","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib182","unstructured":"M. E. Flaugh. US Patent 4,997,845, 1991."},{"key":"10.1016\/j.ejmech.2019.111847_bib183","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1021\/cg300398a","article-title":"Symmetry breaking: Polymorphic form selection by enantiomers of the melatonin agonist and its missing polymorph","volume":"12","author":"Stephenson","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejmech.2019.111847_bib184","unstructured":"M. E. Flaugh. European Patent 0281242B1, 1992."},{"key":"10.1016\/j.ejmech.2019.111847_bib185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000014564","article-title":"Structure-affinity relationships of indole-based melatonin analogs","volume":"8","author":"Spadoni","year":"1999","journal-title":"Biol. Signals Recept."},{"key":"10.1016\/j.ejmech.2019.111847_bib186","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.bmc.2007.04.013","article-title":"7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity","volume":"15","author":"Faust","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib187","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.115.229989","article-title":"Alternative radioligands for investigating the molecular pharmacology of melatonin receptors","volume":"356","author":"Legros","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111847_bib188","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/jm200385u","article-title":"Synthesis of a novel series of tricyclic dihydrofuran derivatives: Discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1\/MT2) ligands","volume":"54","author":"Koike","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib189","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.ejmech.2011.06.030","article-title":"Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands","volume":"46","author":"El Kazzouli","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib190","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1021\/jo8011623","article-title":"Synthesis of C3-substituted 4-azaindoles: an easy access to 4-azamelatonin and protected 4-azatryptophan","volume":"73","author":"Jeanty","year":"2008","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib191","first-page":"1065","article-title":"Synthesis of new melatoninergic ligands including azaindole moiety","volume":"2","author":"Maz\u00e9as","year":"1999","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib192","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.bmcl.2011.02.097","article-title":"Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists","volume":"21","author":"Jeanty","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111847_bib193","doi-asserted-by":"crossref","first-page":"62508","DOI":"10.1039\/C6RA10812A","article-title":"Design, synthesis and biological evaluation of fluorescent ligands for MT1 and\/or MT2 melatonin receptors","volume":"6","author":"Viault","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111847_bib194","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/bph.13856","article-title":"Design and validation of the first cell-impermeant melatonin receptor agonist","volume":"174","author":"Gbahou","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejmech.2004.03.005","article-title":"Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors","volume":"39","author":"Larraya","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib196","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0040-4039(01)02359-0","article-title":"Synthesis of 6,7,8,9-tetrahydropyrido[2,3-b]indolizine and 3,4-dihydro-2H-pyrido[2\u2019,3\u2019:4,5]pyrrolo[2,1-b][1,3]oxazine derivatives as new melatonin receptor","volume":"43","author":"Van de Poel","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib197","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.bmc.2005.10.042","article-title":"Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation","volume":"14","author":"Elsner","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib198","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.tetlet.2013.02.078","article-title":"Synthesis of pyrazolo[1,5-a]pyridines by thermal intramolecular cyclization","volume":"54","author":"Hoashi","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib199","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.tet.2006.10.081","article-title":"Synthesis and pharmacological evaluation of 6a,7-dihydro-6H,13H-pyrazino[1,2-a:4,5-a\u2019]diindole analogs as melatonin receptor ligands","volume":"63","author":"Attia","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.111847_bib200","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1039\/B705550A","article-title":"NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a\u2019]diindole analogues as melatonin receptor ligands","volume":"5","author":"Attia","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib201","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/jm980684+","article-title":"Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles","volume":"43","author":"Faust","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib202","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/jm00072a010","article-title":"Chemistry, binding affinities, and behavioral proteperites of a new class of antineophobic mitochondrial DBI receptor complex (MDRC) ligands","volume":"36","author":"Kozikowski","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib203","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10593-009-0350-3","article-title":"Synthesis of the new heterocyclic system, indolo[2,1-b]benzoxazine","volume":"45","author":"Osyanin","year":"2009","journal-title":"Chem. Heterocycl. Comp."},{"key":"10.1016\/j.ejmech.2019.111847_bib204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/ml4004155","article-title":"Original design of fluorescent ligands by fusing BODIPY and melatonin neurohormone","volume":"5","author":"Thireau","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111847_bib205","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0014-827X(01)01125-9","article-title":"Synthesis of new tricyclic melatoninergic ligands","volume":"56","author":"Tsotinis","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.ejmech.2019.111847_bib206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0928-0987(03)00020-4","article-title":"Synthesis and biological evaluation of new \u03b2,\u03b2\u2019-disubstituted 6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl ethylamido melatoninergic ligands","volume":"18","author":"Tsotinis","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.111847_bib207","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejmech.2007.06.003","article-title":"Synthesis and in\u00a0vivo anti-mutagenic activity of novel melatonin derivatives","volume":"43","author":"Elmegeed","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib208","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.ejmech.2010.09.017","article-title":"Potent neuroprotective role of novel melatonin derivatives for management of central neuropathy induced by acrylamide in rats","volume":"45","author":"Ahmed","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib209","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ejmech.2007.01.027","article-title":"Evaluation of the anti-inflammatory and anti-nociceptive activities of novel synthesized melatonin analogues","volume":"42","author":"Elmegeed","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib210","author":"Fourtillan","year":"2001"},{"key":"10.1016\/j.ejmech.2019.111847_bib211","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2478\/BF02476198","article-title":"The synthesis and the structure elucidation of N,O-diacetyl derivative of cyclic 3-hydroxymelatonin","volume":"2","author":"Siwicka","year":"2004","journal-title":"Open Chem"},{"key":"10.1016\/j.ejmech.2019.111847_bib212","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1021\/jm100529e","article-title":"Synthesis and characterization of novel indole derivatives reveal improved therapeutic agents for treatment of ischemia\/reperfusion (I\/R) injury","volume":"53","author":"Bi","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib213","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3987\/COM-11-12345","article-title":"A\u00a0novel synthesis of 3,4,5,6-tetrahydro-7-hydroxy-1H-azepino[5,4,3-cd]indole derivatives from serotonin","volume":"83","author":"Yamada","year":"2011","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.111847_bib214","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1248\/cpb.49.1159","article-title":"Chemistry of indoles. CVII. A novel synthesis of 3,4,5,6-tetrahydro-7-hydroxy-1H-azepino[5,4,3-cd]indoles and a new finding on Pictet-Spengler reaction","volume":"49","author":"Somei","year":"2001","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.111847_bib215","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/ja00245a031","article-title":"\u03b2-carbolines from the antiviral caribbean tunicate Eudistoma olivaceum","volume":"109","author":"Rinehart","year":"1987","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111847_bib216","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jhet.5570220146","article-title":"An alternative synthesis of 3-amino-1,2,3,4-tetrahydrocarbazoles","volume":"22","author":"Bird","year":"1985","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib217","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0960-894X(01)80566-7","article-title":"Mapping the melatonin receptor. 2. Synthesis and biological activity of indole derived melatonin analogues with restricted conformations of the C-3 amidoethane side chain","volume":"4","author":"Garratt","year":"1994","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111847_bib218","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(95)00489-0","article-title":"Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogue","volume":"287","author":"Sugden","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111847_bib219","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/jm970246n","article-title":"Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles","volume":"41","author":"Davies","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib220","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/jm960651z","article-title":"Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study","volume":"40","author":"Spadoni","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib221","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.bmc.2005.04.064","article-title":"Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues","volume":"13","author":"Bedini","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111847_bib222","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ejmech.2007.01.005","article-title":"Design, synthesis and melatoninergic activity of new unsubstituted and \u03b2,\u03b2\u2032-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides","volume":"42","author":"Tsotinis","year":"2007","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:01:29Z","timestamp":1759327289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419309997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":222,"alternative-id":["S0223523419309997"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111847","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indole-based melatonin analogues: Synthetic approaches and biological activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111847"}}